Collectively, these data suggest that SPP1+ TAMs are associated with unfavorable clinical outcomes in patients with ICC and correlate closely with immune infiltrates in the ICC tumor ecosystem. Here, SPP1 is linked to intrahepatic cholangiocarcinoma.